A UC Berkeley compound increased energy expenditure in mice by up to 18%, improving blood sugar control, reducing blood and liver fat, and promoting weight loss without significant muscle loss. It enhanced the effects of Ozempic and Wegovy, but its safety and efficacy in humans remain unproven.